Human Peripheral Blood Dendritic Cells – Monocyte-Derived Myeloid Dendritic Cells

Description

Human Peripheral Blood Monocyte-Derived Myeloid Dendritic Cells are differentiated from peripheral blood monocytes through primary culture and subsequently cryopreserved. These cells serve as a representative model for studying dendritic cell biology, particularly when direct access to circulating dendritic cells is limited due to their low abundance. They are increasingly explored as potential cellular adjuvants in cancer immunotherapy. Studies also indicate their involvement in inflammatory and infectious responses, with functional roles that may vary in autoimmune conditions. These cells exhibit limited proliferative capacity and should be handled gently, avoiding repeated freeze-thaw cycles during in vitro studies. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.